The DOI matches its Crossref record; 121 of the 122 references it cites were found in a registry or an index.
Adrenocorticotropin Insensitivity Syndromes
Abstract
I. Introduction II. Familial Glucocorticoid Deficiency A. Clinical presentation B. Investigation C. Treatment D. Pathogenesis III. Triple A Syndrome A. Clinical features B. Treatment C. Pathogenesis D. Mapping of triple A syndrome gene E. Candidate genes IV. Acquired ACTH Resistance V. Conclusions ACTH INSENSITIVITY syndromes comprise an uncommon group of disorders that, current evidence suggests, have at least three different molecular etiologies. The aim of this review is to examine the various forms of clinical presentation in conjunction with the current knowledge of the molecular and genetic background of these diseases, which as will be seen, reveals some interesting and unexpected physiological and anatomical relationships. The principal pathways by which ACTH stimulates adrenal steroidogenesis are summarized in Fig. 1. The syndrome of ACTH insensitivity was originally described by Shepard et al. (1) in 1959 in a paper entitled “Familial Addison’s Disease,” which reported the case of two sisters who had what has subsequently become known most frequently as familial glucocorticoid deficiency, isolated glucocorticoid deficiency, adrenal unresponsiveness to ACTH, or hereditary unresponsiveness to ACTH. For uniformity, and since it was the first of these terms to be coined and has been most frequently used in the literature, we continue to refer to this disorder as familial glucocorticoid deficiency (FGD), although the other terms are equally descriptive (MIM*202200). Essential features of the mechanism of action of ACTH in stimulating steroidogenesis in the adrenal fasciculata cell. ACTH binds to and activates its cognate seven-transmembrane domain receptor at the cell surface, resulting in activation of the heterotrimeric G protein by exchange of GTP for GDP and dissociation of the α-subunit from the βγ-subunits. Gsα then stimulates membrane-associated adenylate cyclase to synthesize cAMP, which in turn activates protein kinase A (PKA) in the cytosol. The catalytic subunits of PKA dissociate and phosphorylate target factors, which include the cAMP response element binding protein (CREB). CREB and other unidentified factors which may also be substrates for PKA then activate the steroidogenic acute regulatory protein (StAR) protein and induce the transcription of the steroidogenic enzymes CYP11A (P450 scc), CYP17 (17α-hydroxylase), CYP21 (21-hydroxylase), and CYP11B1 (11β-hydroxylase), which ultimately results in an increased rate of cortisol synthesis. Although it had been recognized previously as a variant of FGD, the other distinct syndrome of ACTH insensitivity that we shall discuss was identified as such in a paper by Allgrove et al. in 1978 (2). This syndrome became known as Allgrove syndrome or, more recently, as the triple A syndrome for reasons that will be described. As we shall show, this is a distinct clinical and genetic entity that shares with FGD only the feature of ACTH insensitivity. The typical presentation of patients with ACTH insensitivity is almost always as a consequence of glucocorticoid deficiency. Excessive skin pigmentation as a result of high circulating ACTH is occasionally reported as one of the primary complaints. Since these disorders are inherited diseases (see below), it might be expected that glucocorticoid deficiency should be manifest in the neonatal period. Although this is true for some patients, many are not diagnosed until infancy or later childhood. The nature of the clinical presentation in the neonate differs from that in later childhood and in most patients takes the form of hypoglycemia (3–8). This may not be profound and usually responds to more frequent feeding. Often these patients are significantly jaundiced and may require phototherapy (4, 5, 7, 8). In some cases this appears to result from a transient hepatitis, which may be glucocorticoid dependent (9). Perhaps surprisingly, excessive pigmentation of the skin is occasionally seen the first of although this is usually first and or as is a feature in infancy and childhood. may at this with a that may be will frequent which an to feature of FGD is childhood which responds to of glucocorticoid a of other features frequent and to and skin pigmentation be features be with a of childhood Addison’s and in many patients this is the FGD differs from Addison’s in one patients with FGD deficiency, and of and This the that by the adrenal is the of and is of ACTH, although ACTH in the of the adrenal are the of ACTH. In and are from the from of in the known as Although to the for it is that ACTH is for adrenal since patients with FGD evidence of an and have adrenal patients with the clinical of FGD have been reported to be 7, for this has been and not to have been of the of the patients a of or adrenal or other with adrenal resulting from other such as Addison’s are not and the excessive usually clinical is in these patients, and the in This may be of in the of the (see The described should to a of an to which in the
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FGD1 is caused by autosomal recessive mutations in the gene for the G protein-coupled ACTH receptor (MC2R) (119, 622, 623).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [622]
Citations
Cites
International System for Human Cytogenetic Nomenclature
National Cancer Institute (2020) · Definitions · doi:10.32388/78qroa · Cited by 6,831
Moll, R., Franke, W. W., Schiller, D. L., Geiger, B., & Krepler, R. (1982) · Cell · doi:10.1016/0092-8674(82)90400-7 · Cited by 5,239
A comprehensive genetic map of the human genome based on 5,264 microsatellites
Dib, C., Fauré, S., Fizames, C., Samson, D. S., Drouot, N., Alain Vignal, A., Millasseau, P., Marc, S., Kazan, J., Seboun, E., et al. (1996) · Nature · doi:10.1038/380152a0 · Cited by 2,927
ISCN 1995 An international system for human cytogenetic nomenclature
Mitelman, F. (1995) · Cited by 1,930
The 1993–94 Généthon human genetic linkage map
Gyapay, G., Morissette, J., Alain Vignal, A., Dib, C., Fizames, C., Millasseau, P., Marc, S., Bernardi, G., Lathrop, M. G., & Weissenbach, J. (1994) · Nature Genetics · doi:10.1038/ng0694supp-246 · Cited by 1,835
The cloning of a family of genes that encode the melanocortin receptors
Mountjoy, K. G., Robbins, L. S., Mortrud, M. T., & Cone, R. D. (1992) · Science · doi:10.1126/science.1325670 · Cited by 1,635
Molecular cloning, expression, and gene localization of a fourth melanocortin receptor
Gantz, I., Miwa, H., Konda, Y., Shimoto, Y., Tashiro, T., Watson, S. J., DelValle, J., & Yamada, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82452-8 · Cited by 846
Roselli-Rehfuss, L., Mountjoy, K. G., Robbins, L. S., Mortrud, M. T., Low, M. J., Tatro, J. B., Entwistle, M. L., Simerly, R. B., & Cone, R. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.8856 · Cited by 722
Molecular cloning of a novel melanocortin receptor.
Gantz, I., Konda, Y., Tashiro, T., Shimoto, Y., Miwa, H., Munzert, G. M., Watson, S. J., DelValle, J., & Yamada, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53088-x · Cited by 681
Familial glucocorticoid deficiency with achalasia of the cardia and deficient tear production
Allgrove, J., Clayden, G. S., Grant, D. B., & Macaulay, J. C. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91268-0 · Cited by 448
Research works printed but not linked: 13
- Elias, 1997, Functional analysis of the I44M mutant ACTH receptor found in familial glucocorticoid deficiency., J Endocrinol, 155, 29
- Petrykowski, 1975, Familiäre Glucocorticoidinsuffizienz., Klin Padiatr, 187, 198
- Yordam, 1996, Familial glucocorticoid deficiency: clinical spectrum and endocrine details in five Turkish children, Horm Res, 46, 92
- Hammami, 1989, Association d’une maladie d’Addison, d’une achalasie du cardia et d’une alacrymation. A propos de deux observations., Ann Pediatr (Paris), 36, 279
- Várkonyi Á, Jukesz, 1992, Simultaneous occurrence of selective ACTH insensitivity, achalasia and alacrima accompanied by hyperlipoproteinaemia., Acta Paediatr Hung, 32, 31
- Degli Esposti, 1985, Sindrome familiare di ipoglicocorticismo da insensibilatà all’ACTH, acalasia, alacrima, con associata neuromiopatia distale., Minerva Pediatr, 37, 353
- Weber, 1997, Clinical variability and molecular genetics in a family with triple A syndrome, Horm Res, 48, 191
- Rezvani, 1983, Familial glucocorticoid deficiency (FGD) with lacrimal and esophageal dysfunction: evidence against an ACTH “receptor defect.”, Pediatr Res, 17, 170
- Auge, 1985, Addison’s disease in littermates., Vet Med (Praha), 80, 43
- Acta Neurobiol Exp (Warsz), 50, 353
- Johnson, 1983, Autonomic failure and the eyes, In: Bannister R (ed) Autonomic Failure. A Textbook of Clinical Disorders of the Autonomous Nervous System. Oxford University Press, Oxford, UK, pp, 509
- Krauter, 1995, A second-generation YAC contig map of human chromosome 12, Nature, 377, 321
- Kucherlapati, Cytogenet Cell Genet, 78, 82
Cited by
Sorted by citations
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Metherell, L. A., Chapple, J. P., Cooray, S., David, A., Becker, C., Rüschendorf, F., Naville, D., Begeot, M., Khoo, B., Nürnberg, P., et al. (2005) · Nature Genetics · doi:10.1038/ng1501 · Cited by 437
Self-citationIshimoto, H., & Jaffe, R. B. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0001 · Cited by 379
Mutant WD-repeat protein in triple-A syndrome
Tullio-Pelet, A., Salomon, R., Hadj-Rabia, S., Mugnier, C., de Laet, M.-H., Chaouachi, B., Bakiri, F., Brottier, P., Cattolico, L., Penet, C., et al. (2000) · Nature Genetics · doi:10.1038/81642 · Cited by 312
Krude, H., Biebermann, H., Schnabel, D., Tanšek, M. Ž., Theunissen, P., Mullis, P. E., & Grüters, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030502 · Cited by 313
MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans
Hughes, C. R., Guasti, L., Meimaridou, E., Chuang, C.-H., Schimenti, J. C., King, P., Costigan, C., Clark, A., & Metherell, L. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60224 · Cited by 260
Self-citationTriple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene
Handschug, K. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.3.283 · Cited by 257
The nuclear pore complex protein ALADIN is mislocalized in triple A syndrome
Cronshaw, J. M., & Matunis, M. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031047100 · Cited by 173
Chida, D., Nakagawa, S., Nagai, S., Sagara, H., Katsumata, H., Imaki, T., Suzuki, H., Mitani, F., Ogishima, T., Shimizu, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706953104 · Cited by 166
OVARIAN AND ADRENAL FUNCTION IN POLYCYSTIC OVARY SYNDROME
Rosenfield, R. L. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70070-0 · Cited by 164
Clinical and genetic characterization of families with triple A (Allgrove) syndrome
Houlden, H. (2002) · Brain · doi:10.1093/brain/awf270 · Cited by 156
Extra-adrenal glucocorticoid biosynthesis: implications for autoimmune and inflammatory disorders
Slominski, R. M., Tuckey, R. C., Manna, P. R., Jetten, A. M., Postlethwaite, A., Raman, C., & Slominski, A. T. (2020) · Genes & Immunity · doi:10.1038/s41435-020-0096-6 · Cited by 155
Tao, Y. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.02.008 · Cited by 151
Minireview: Transcriptional Regulation of Adrenocortical Development
Hammer, G. D., Parker, K. L., & Schimmer, B. P. (2004) · Endocrinology · doi:10.1210/en.2004-1385 · Cited by 143
Implications of Proopiomelanocortin (POMC) Mutations in Humans: The POMC Deficiency Syndrome
Krude, H., & Grüters, A. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(99)00213-1 · Cited by 145
Minireview: the melanocortin 2 receptor accessory proteins
Webb, T. R., & Clark, A. J. L. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0283 · Cited by 125
Self-citationSwords, F., Baig, A. H., Malchoff, D. M., Malchoff, C. D., Thorner, M. O., King, P., Hunyady, L., & Clark, A. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0099 · Cited by 108
Self-citationTall stature in familial glucocorticoid deficiency
Elias, L. L. K., Huebner, A., Metherell, L., Canas, J. A., Warne, G. L., Bitti, M. L. M., Cianfarani, S., Clayton, P., Savage, M. O., & Clark, A. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01122.x · Cited by 102
Self-citationTriple A syndrome: genotype–phenotype assessment
Prpić, I., Huebner, A., Peršić, M., Handschug, K., & Pavletić, M. (2003) · Clinical Genetics · doi:10.1034/j.1399-0004.2003.00070.x · Cited by 99
Adrenal gland development and defects
Kempná, P., & Flück, C. E. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.07.008 · Cited by 97
Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2
Chung, T., Chan, L. F., Metherell, L., & Clark, A. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03663.x · Cited by 92
Self-citationColl, A. P., Challis, B., Yeo, G. S. H., Snell, K. R. S., Piper, S. J., Halsall, D. J., Thresher, R. R., & O’Rahilly, S. (2004) · Endocrinology · doi:10.1210/en.2004-0491 · Cited by 92
Adrenocortical Development, Maintenance, and Disease
Yates, R., Katugampola, H., Cavlan, D., Cogger, K., Meimaridou, E., Hughes, C. R., Metherell, L., Guasti, L., & King, P. (2013) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-416021-7.00007-9 · Cited by 100
Mutations in the Human Proopiomelanocortin Gene
Krude, H., Biebermann, H., & Grüters, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03185.x · Cited by 89
Noon, L., Franklin, J., King, P., Goulding, N., Hunyady, L., & Clark, A. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1740017 · Cited by 88
Self-citationLin, L., Hindmarsh, P. C., Metherell, L., Alzyoud, M., Alali, M., Brain, C. E., Clark, A. J. L., Dattani, M., & Achermann, J. C. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02709.x · Cited by 88
Self-citationThe melanocortin receptors and their accessory proteins
Ramachandrappa, S., Gorrigan, R. J., Clark, A. J. L., & Chan, L. F. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00009 · Cited by 87
Self-citationStorr, H. L., Kind, B., Parfitt, D. A., Chapple, J. P., Lorenz, M., Koehler, K., Huebner, A., & Clark, A. J. L. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0056 · Cited by 84
Self-citationInherited ACTH insensitivity illuminates the mechanisms of ACTH action
Clark, A. J. L., Metherell, L. A., Cheetham, M. E., & Huebner, A. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.10.006 · Cited by 82
Self-citationRegulation of zonation and homeostasis in the adrenal cortex
Pignatti, E., Leng, S., Carlone, D. L., & Breault, D. T. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.09.003 · Cited by 86
Chung, T. T., Webb, T. R., Chan, L. F., Cooray, S. N., Metherell, L. A., King, P. J., Chapple, J. P., & Clark, A. J. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1744 · Cited by 82
Self-citationMultiple melanocortin receptors are expressed in bone cells
Zhong, Q., Sridhar, S., Ruan, L., Ding, K., XIE, D., Insogna, K. L., Kang, B., XU, J., Bollag, R. J., & Isales, C. M. (2005) · Bone · doi:10.1016/j.bone.2005.01.020 · Cited by 82
ACTH Receptor (MC2R) Specificity: What Do We Know About Underlying Molecular Mechanisms?
Frīdmanis, D., Roga, A., & Kloviņš, J. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00013 · Cited by 82
The nuclear pore complex: disease associations and functional correlations
Cronshaw, J. M., & Matunis, M. J. (2003) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2003.11.005 · Cited by 78
Sandrini, F., Farmakidis, C., Kirschner, L. S., Wu, S.-M., Pelet, A., Lyonnet, S., Metzger, D. L., Bourdony, C. J., Tiosano, D., Chan, W., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.8037 · Cited by 77
Triple A syndrome: 32 years experience of a single centre (1977–2008)
Milenković, T., Zdravković, D., Savić, N., Todorovic, S., Mitrović, K., Koehler, K., & Huebner, A. (2010) · European Journal of Pediatrics · doi:10.1007/s00431-010-1222-7 · Cited by 75
Regulation of Long Bone Growth in Vertebrates; It Is Time to Catch Up
Roselló‐Díez, A., & Joyner, A. L. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1048 · Cited by 78
Böhm, M., & Grässel, S. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1016 · Cited by 74
Karpac, J., Ostwald, D., Bui, S., Hunnewell, P., Shankar, M., & Hochgeschwender, U. (2005) · Endocrinology · doi:10.1210/en.2004-1290 · Cited by 73
The Triple A Syndrome Is Due to Mutations in ALADIN, a Novel Member of the Nuclear Pore Complex
Huebner, A., Kaindl, A. M., Knobeloch, K., Petzold, H. A., Mann, P., & Koehler, K. (2004) · Endocrine Research · doi:10.1081/erc-200044138 · Cited by 73
Melanocortin receptors and their accessory proteins
Cooray, S. N., & Clark, A. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.07.015 · Cited by 72
Self-citationElias, L. L. K., Huebner, A., Pullinger, G. D., Mirtella, A., & Clark, A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5924 · Cited by 72
Self-citationFamilial Glucocorticoid Deficiency: Advances in the Molecular Understanding of ACTH Action
Chan, L. F., Clark, A. J. L., & Metherell, L. (2007) · Hormone Research in Paediatrics · doi:10.1159/000111810 · Cited by 70
Self-citationFaßnacht, M., Hahner, S., Hansen, I. A., Kreutzberger, T., Zink, M., Adermann, K., Jakob, F. J., Troppmair, J., & Allolio, B. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021318 · Cited by 68
The diagnosis and investigation of adrenal insufficiency in adults
Wallace, I., Cunningham, S., & Lindsay, J. (2009) · Annals of Clinical Biochemistry · doi:10.1258/acb.2009.009101 · Cited by 43
Swords, F., Noon, L. A., King, P., & Clark, A. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.052 · Cited by 67
Self-citationGorrigan, R. J., Guasti, L., King, P., Clark, A. J. L., & Chan, L. F. (2011) · Journal of Molecular Endocrinology · doi:10.1530/jme-11-0011 · Cited by 66
Self-citationIntracellular signaling mechanisms of the melanocortin receptors: current state of the art
Rodrigues, A. R., Almeida, H., & Gouveia, A. M. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1800-3 · Cited by 64
Triple-A syndrome: a wide spectrum of adrenal dysfunction
Roucher‐Boulez, F., de la Perrière, A. B., Jacquez, A., Chau, D., Guignat, L., Vial, C., Morel, Y., Nicolino, M. P., Raverot, G., & PUGEAT, M. M. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0642 · Cited by 62
Adrenal cortex development and related disorders leading to adrenal insufficiency
Pignatti, E., & Flück, C. E. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111206 · Cited by 67
Flück, C. E., Martens, J. W. M., Conte, F. A., & Miller, W. L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020501 · Cited by 57
Pathophysiology of melanocortin receptors and their accessory proteins
Novoselova, T. V., Chan, L. F., & Clark, A. (2018) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2018.02.002 · Cited by 59
Self-citationBioinactive ACTH causing glucocorticoid deficiency
Samuels, M. E., Gallo-Payet, N., Pinard, S., Hasselmann, C., Magne, F., Patry, L., Chouinard, L., Schwartzentruber, J., René, P., Sawyer, N., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3199 · Cited by 55
Sarathi, V., & Shah, N. S. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6448-9_1 · Cited by 54
Adrenal cortex tissue homeostasis and zonation: A WNT perspective
Drelon, C., Berthon, A. S., Mathieu, M., Martinez, A., & Val, P. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.12.014 · Cited by 64
The genetics of familial glucocorticoid deficiency
Clark, A., Chan, L. F., Chung, T., & Metherell, L. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.09.006 · Cited by 51
Self-citationMolecular Basis of Adrenal Insufficiency
Fujieda, K., & Tajima, T. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000159568.31749.4d · Cited by 50
The Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Wiley eBooks · doi:10.1002/9781444316728.ch13 · Cited by 51
DAX1 and its network partners: exploring complexity in development
Clipsham, R. C., & McCabe, E. R. B. (2003) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.08.023 · Cited by 54
Role of ALADIN in Human Adrenocortical Cells for Oxidative Stress Response and Steroidogenesis
Jühlen, R., Idkowiak, J., TAYLOR, A. E. R., Kind, B., Arlt, W., Huebner, A., & Koehler, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124582 · Cited by 49
Triple a Syndrome—Clinical Aspects and Molecular Genetics
Huebner, A., Yoon, S., Özkınay, F., Hilscher, C., Lee, H., Clark, A. J. L., & Handschug, K. (2000) · Endocrine Research · doi:10.3109/07435800009048596 · Cited by 49
Self-citationTriple A syndrome (Allgrove syndrome): improving outcomes with a multidisciplinary approach
Flokas, M. E., Tomani, M., Agdere, L., & Brown, B. (2019) · Pediatric Health Medicine and Therapeutics · doi:10.2147/phmt.s173081 · Cited by 48
Imaki, T., Naruse, M., & Takano, K. (2004) · Endocrine Journal · doi:10.1507/endocrj.51.89 · Cited by 48
Chen, M., Aprahamian, C. J., Kesterson, R. A., Harmon, C. M., & Yang, Y. (2007) · Biochemistry · doi:10.1021/bi700125e · Cited by 48
Huebner, A., Mann, P., Rohde, E., Kaindl, A. M., Witt, M., Verkade, P., Jakubiczka, S., Menschikowski, M., Stoltenburg, G., & Koehler, K. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.5.1879-1887.2006 · Cited by 44
Adrenal cortex and its disorders
Miller, W. L., & Flück, C. E. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00022-6 · Cited by 45
Phenotype–genotype spectrum of AAA syndrome from Western India and systematic review of literature
Patt, H., Koehler, K., Lodha, S., Jadhav, S. S., Yerawar, C. G., Huebner, A., Thakkar, K., Arya, S., Nair, S. V. G., Goroshi, M., et al. (2017) · Endocrine Connections · doi:10.1530/ec-17-0255 · Cited by 42
Effects of melanocortins on adrenal gland physiology
Chan, L. F., Metherell, L., & Clark, A. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.11.041 · Cited by 40
Self-citationMolecular signatures of human melanocortin receptors for ligand binding and signaling
Yang, Y., & Harmon, C. M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.04.025 · Cited by 40
Recent advances in the molecular genetics of congenital and acquired primary adrenocortical failure
Vaidya, B., Pearce, S. H. S., & Kendall‐Taylor, P. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01116.x · Cited by 39
Yang, L.-K., Hou, Z.-S., & Tao, Y. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165973 · Cited by 40
MYG1, novel melanocyte related gene, has elevated expression in vitiligo
Kingo, K., Philips, M., Aunin, E., Luuk, H., Karelson, M., Rätsep, R., Silm, H., Vasar, E., & Kõks, S. (2006) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2006.08.001 · Cited by 39
Expression of the human melanocortin-2 receptor in different eukaryotic cells
Rached, M., Mourabit, H. E., Buronfosse, A., Blondet, A., Naville, D., Bégeot, M., & Penhoat, A. (2005) · Peptides · doi:10.1016/j.peptides.2004.11.037 · Cited by 38
Proudnikov, D., Hamon, S., Ott, J., & Kreek, M. J. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.02.042 · Cited by 36
Marques, P., & Korbonits, M. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.11.001 · Cited by 36
Melanocortin receptor accessory proteins in adrenal gland physiology and beyond
Novoselova, T. V., Jackson, D., Campbell, D. C., Clark, A., & Chan, L. F. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0501 · Cited by 36
Self-citationEvans, J. F., Niu, Q., Canas, J. A., Shen, C.-L., Aloia, J. F., & Yeh, J. K. (2004) · Bone · doi:10.1016/j.bone.2004.03.015 · Cited by 35
G Protein-Coupled Receptors: What a Difference a ‘Partner’ Makes
Roux, B. T., & Cottrell, G. S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15011112 · Cited by 37
Adrenocorticotropin Resistance Syndromes
Cooray, S. N., Chan, L. F., Metherell, L., Storr, H. L., & Clark, A. (2008) · KARGER eBooks · doi:10.1159/000134828 · Cited by 35
Self-citationImamine, H., Mizuno, H., Sugiyama, Y., Ohro, Y., Sugiura, T., & Togari, H. (2005) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.205.123 · Cited by 35
ACTH signalling and adrenal development: lessons from mouse models
Novoselova, T. V., King, P., Guasti, L., Metherell, L., Clark, A., & Chan, L. F. (2019) · Endocrine Connections · doi:10.1530/ec-19-0190 · Cited by 34
Self-citationA Novel Variant of Familial Glucocorticoid Deficiency Prevalent among the Irish Traveler Population
O’Riordan, S., Lynch, S. A., Hindmarsh, P. C., Chan, L. F., Clark, A., & Costigan, C. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0034 · Cited by 34
Self-citationChan, L. F., Metherell, L., Krude, H., Ball, C., O’Riordan, S., Costigan, C., Lynch, S. A., Savage, M. O., Cavarzere, P., & Clark, A. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03511.x · Cited by 33
Self-citationNEW INSIGHTS INTO THE MOLECULAR BASIS OF THE TRIPLE A SYNDROME
Huebner, A., Kaindl, A. M., Braun, R., & Handschug, K. (2002) · Endocrine Research · doi:10.1081/erc-120016998 · Cited by 33
Unusual Presentation of Familial Glucocorticoid Deficiency with a NovelMRAPMutation
Modan‐Moses, D., Ben‐Zeev, B., Hoffmann, C., Zaccai, T. C. F., Bental, Y. A., Pinhas‐Hamiel, O., & Anikster, Y. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0687 · Cited by 33
Melanocortin receptor accessory proteins in adrenal disease and obesity
Jackson, D. S., Ramachandrappa, S., Clark, A., & Chan, L. F. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00213 · Cited by 32
Self-citationCuring kinetics and thermomechanical behaviour of co‐anhydride cured aminoglycidyl epoxy resins
Rocks, J., George, G. A., & Vohwinkel, F. (2003) · Polymer International · doi:10.1002/pi.1286 · Cited by 32
Heterogeneity in the molecular basis of ACTH resistance syndrome.
Collares, C. V. A., Antunes‐Rodrigues, J., Moreira, A. C., Nesi-França, S., Pereira, L. A., Soares, M. M. S., Elías, J., Clark, A., de Castro, M., & Elias, L. L. K. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0079 · Cited by 32
Self-citationHofland, J., Delhanty, P. J. D., Steenbergen, J., Hofland, L. J., van Koetsveld, P. M., van Nederveen, F. H., de Herder, W. W., Feelders, R. A., & de Jong, F. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2328 · Cited by 30
ACTH 1-24 inhibits proliferation of adrenocortical tumors in vivo
Zwermann, O., Schulte, D. M., Reincke, M., & Beuschlein, F. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01983 · Cited by 29
News about the genetics of congenital primary adrenal insufficiency
Roucher‐Boulez, F., Mallet-Motak, D., Tardy-Guidollet, V., Menassa, R., Goursaud, C., Plotton, I., & Morel, Y. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.03.016 · Cited by 27
The Adrenal Cortex and Its Disorders
Miller, W. L., Achermann, J. C., & Flück, C. E. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50017-x · Cited by 28
Two siblings with triple A syndrome and novel mutation presenting as hereditary polyneuropathy
Dumić, M., Barišić, N., Rojnić-Putarek, N., Kuŝec, V., Stanimirović, A., Koehler, K., & Huebner, A. (2010) · European Journal of Pediatrics · doi:10.1007/s00431-010-1314-4 · Cited by 27
Inherited adrenal hypoplasia: not just for kids!
Lin, L., & Achermann, J. C. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.01988.x · Cited by 27
Janes, M. E., Chu, K. M. E., Clark, A., & King, P. (2008) · Endocrinology · doi:10.1210/en.2007-0949 · Cited by 25
Self-citationBarzon, L., Maffei, P., Sonino, N., Pilon, C., Baldazzi, L., Balsamo, A., Del Maschio, O., Masi, G., Trevisan, M., Pacenti, M., et al. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03346358 · Cited by 24
WD40-Repeat Proteins in Ciliopathies and Congenital Disorders of Endocrine System
Kim, Y.-J., & Kim, S. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.302 · Cited by 23
Late-Onset Triple A Syndrome: A Risk of Overlooked or Delayed Diagnosis and Management
Salmaggi, A., Zirilli, L., Pantaleoni, C., Joanna, G. D., Sorbo, F. D., Koehler, K., Krumbholz, M., Huebner, A., & Rochira, V. (2008) · Hormone Research in Paediatrics · doi:10.1159/000161867 · Cited by 24
Rumié, H., Metherell, L., Clark, A., Beauloye, V., & Maes, M. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0242 · Cited by 23
Self-citationChromosomal fragility in patients with triple A syndrome
Reshmi-Skarja, S., Huebner, A., Handschug, K., Finegold, D. N., Clark, A. J. L., & Gollin, S. M. (2002) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.10846 · Cited by 23
Self-citation
Metadata
- Authors
- Clark, A. J. L., & Weber, A.
- Affiliations
- St Bartholomew's Hospital (GB)
- Technische Universität Dresden (DE)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 1998-12-01
- Volume
- 19
- Issue
- 6
- Pages
- 828-843
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2117973418
- Cited by
- 234
- References
- 122
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 7 · 2020: 9 · 2019: 3 · 2018: 9 · 2017: 12 · 2016: 2 · 2015: 10 · 2014: 10 · 2013: 8 · 2012: 9
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Deutsche Forschungsgemeinschaft
- Albert-Ludwigs-Universität Freiburg
- Hospital for Sick Children
- Universität Zürich
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- familial glucocorticoid deficiency, triple A syndrome, ACTH receptor, G protein signaling, steroidogenesis, adrenal cortex, steroidogenic acute regulatory protein, CREB, CYP11A, CYP17, CYP21, CYP11B1
- MeSH terms
- Adrenal Glands, Adrenocorticotropic Hormone, Animals, Humans, Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review